Jilin University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Changchun United States (1946)

Organization Overview

First Clinical Trial
2007
NCT01495468
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

13.The Second Hospital of Jilin University | 2nd Floor, Building 1, No. 71, Xinmin Street, Changchun, Jilin Province | Affiliated Hospital of Jilin University, Changchun,China | Aiping Shi | China-Japan Union Hospital, Jilin University | Di Wu | Dong Yang | First Affiliated Hospital of Jilin University | First Hospital Jilin University | First Hospital, Jilin University | First Hospital of Jilin Univerisity | First Hospital of Jilin University | Foshan University Laboratory of Emerging Infectious Disease Institute of Translational Medicine , Jilin University China | Jian Suo | Jilin hematology hospital | Jilin Provincal Cancer Hospital | Jilin Province Cancer Hospital | Jilin University | Jilin University First Affiliated Hospital | Jilin University First Hospital | Jilin University Medical Science Division | jiuwei cui | Junqi Niu | Neuroscience Center, Department of Neurology, The First Hospital of Jilin University | oubai, MD/PhD | Phase I Clinical Trial Laboratory,The First Hospital of Jilin University | Phase I Clinical Trial Unit, The First Hospital of Jilin University | Pneumology Department, The First Hospital of Jilin University | Quan Wang | Second Hospital of Jilin University | the Cancer Center of First Hospital of Jilin University | the chief of the neurology department, the First Hospital of Jilin University | The first affiliated hospital of Jilin University | The First Affiliated Hospital of Jilin University | The First Hospital of Jilin University, Jilin Province | Yi Yang